Eli Lilly (LLY) Inventory Average (2009 - 2026)

Eli Lilly (LLY) has reported Inventory Average for 18 consecutive years, with $14.1 billion the latest figure, recorded in Q1 2026.

• Inventory Average for Q1 2026 came in at $14.1 billion, up 67.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 billion (up 67.3% YoY), and the FY2025 annual result was $10.7 billion, up 59.66% from the prior year.
• Inventory Average was $14.1 billion for Q1 2026 at Eli Lilly, up from $13.0 billion in the prior quarter.
• Over five years, Inventory Average peaked at $14.1 billion in Q1 2026 and troughed at $3.9 billion in Q3 2022.
• Average Inventory Average over 5 years is $7.0 billion, with a median of $5.9 billion recorded in 2024.
• Year-over-year, Inventory Average dropped 0.02% in 2022 and surged 72.27% in 2025.
• Over 5 years, Inventory Average stood at $4.1 billion in 2022, then surged by 31.12% to $5.3 billion in 2023, then surged by 40.98% to $7.5 billion in 2024, then jumped by 72.27% to $13.0 billion in 2025, then advanced by 9.06% to $14.1 billion in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $14.1 billion in Q1 2026, $13.0 billion in Q4 2025, and $11.6 billion in Q3 2025.